Insider filing report for Changes in Beneficial Ownership
- Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
- Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13G
|
UNDER THE SECURITIES EXCHANGE ACT OF 1934
|
Monogram Technologies Inc. (Name of Issuer) |
Common Stock, par value $0.001 per share (Title of Class of Securities) |
609786108 (CUSIP Number) |
12/31/2023 (Date of Event Which Requires Filing of this Statement) |
Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |
![]() |
![]() |
![]() |
SCHEDULE 13G
|
CUSIP No. | 609786108 |
1 | Names of Reporting Persons
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | ||||||||
2 | Check the appropriate box if a member of a Group (see instructions)
![]() ![]() | ||||||||
3 | Sec Use Only | ||||||||
4 | Citizenship or Place of Organization
NEW YORK
| ||||||||
Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
9 | Aggregate Amount Beneficially Owned by Each Reporting Person
2,360,304.00 | ||||||||
10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
![]() | ||||||||
11 | Percent of class represented by amount in row (9)
5.8 % | ||||||||
12 | Type of Reporting Person (See Instructions)
CO |
Comment for Type of Reporting Person: (1) Footnote to Rows 5, 7 and 9: The voting and investment authority of the common stock is vested in those persons who from time to time are the executive officers of Icahn School of Medicine at Mount Sinai ("ISMMS"). (2) Footnote to Row 11: Ownership calculation based on 40,632,367 shares of common stock outstanding as of July 11, 2025.
SCHEDULE 13G
|
CUSIP No. | 609786108 |
1 | Names of Reporting Persons
MOUNT SINAI HEALTH SYSTEM, INC. | ||||||||
2 | Check the appropriate box if a member of a Group (see instructions)
![]() ![]() | ||||||||
3 | Sec Use Only | ||||||||
4 | Citizenship or Place of Organization
NEW YORK
| ||||||||
Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
9 | Aggregate Amount Beneficially Owned by Each Reporting Person
0.00 | ||||||||
10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
![]() | ||||||||
11 | Percent of class represented by amount in row (9)
0 % | ||||||||
12 | Type of Reporting Person (See Instructions)
HC |
Comment for Type of Reporting Person: (1) Footnote to Row 9: As the sole member of ISMMS, Mount Sinai Health System, Inc. ("MSHS") may be deemed to beneficially own the common stock held by ISMMS. MSHS disclaims beneficial ownership of such common stock.
SCHEDULE 13G
|
Item 1. | ||
(a) | Name of issuer:
Monogram Technologies Inc. | |
(b) | Address of issuer's principal executive offices:
3919 Todd Lane, Austin, TX 78744 | |
Item 2. | ||
(a) | Name of person filing:
Collectively the following Reporting Persons are referred to as the "Joint Filers": Icahn School of Medicine at Mount Sinai ("ISMMS") Mount Sinai Health System, Inc. ("MSHS"), sole member of ISMMS The Joint Filers may be deemed to collectively own an aggregate of 2,360,304 shares of common stock of the Issuer. MSHS disclaims beneficial ownership of such common stock. | |
(b) | Address or principal business office or, if none, residence:
The address of the principal business office of each Reporting Person is: One Gustave L. Levy Place New York, NY 10029 | |
(c) | Citizenship:
See Item 4 of the cover pages for citizenship or place of organization of each Reporting Person. | |
(d) | Title of class of securities:
Common Stock, par value $0.001 per share | |
(e) | CUSIP No.:
609786108 | |
Item 3. | If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: | |
(a) | ![]() | |
(b) | ![]() | |
(c) | ![]() | |
(d) | ![]() | |
(e) | ![]() | |
(f) | ![]() | |
(g) | ![]() | |
(h) | ![]() | |
(i) | ![]() | |
(j) | ![]() please specify the type of institution: | |
(k) | ![]() | |
Item 4. | Ownership | |
(a) | Amount beneficially owned:
See Row 9 of cover page for each Reporting Person. | |
(b) | Percent of class:
See Row 11 of cover page for each Reporting Person. %
| |
(c) | Number of shares as to which the person has:
| |
(i) Sole power to vote or to direct the vote:
See Row 5 of cover page for each Reporting Person. | ||
(ii) Shared power to vote or to direct the vote:
See Row 6 of cover page for each Reporting Person. | ||
(iii) Sole power to dispose or to direct the disposition of:
See Row 7 of cover page for each Reporting Person. | ||
(iv) Shared power to dispose or to direct the disposition of:
See Row 8 of cover page for each Reporting Person. | ||
Item 5. | Ownership of 5 Percent or Less of a Class. | |
Item 6. | Ownership of more than 5 Percent on Behalf of Another Person. | |
Not Applicable
| ||
Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. | |
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
See Item 2 above. | ||
Item 8. | Identification and Classification of Members of the Group. | |
Not Applicable
| ||
Item 9. | Notice of Dissolution of Group. | |
Not Applicable
|
Item 10. | Certifications: |
Not Applicable
|
SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|
|
|
Exhibit Information
|
Exhibit 1 - Joint Filing Agreement |